LACTOSE (INDIA)
Back to Income Statement
|
LACTOSE (INDIA) Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹116 Cr | ₹114 Cr | ₹66 Cr | ₹46 Cr | ₹35 Cr |
What is the latest Revenue of LACTOSE (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹116 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹35 Cr |
How is Revenue of LACTOSE (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹116 Cr | 2.20 | |
| Mar2024 | ₹114 Cr | 73.10 | |
| Mar2023 | ₹66 Cr | 43.22 | |
| Mar2022 | ₹46 Cr | 31.39 | |
| Mar2021 | ₹35 Cr | - | |
Compare Revenue of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹131.0 Cr | -0.9% | -10% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -0.9% |
-10% |
4.4% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses